Skip to main content
Chugai Pharmaceutical Co., Ltd. (TYO: 4519)
Japan flag Japan · Delayed Price · Currency is JPY
6,650.00
-52.00 (-0.78%)
Dec 20, 2024, 3:45 PM JST

Chugai Pharmaceutical Revenue

Chugai Pharmaceutical had revenue of 315.68B JPY in the quarter ending September 30, 2024, with 22.40% growth. This brings the company's revenue in the last twelve months to 1.14T, down -10.48% year-over-year. In the year 2023, Chugai Pharmaceutical had annual revenue of 1.11T, down -11.79%.

Revenue (ttm)
1,142.35B
Revenue Growth
-10.48%
P/S Ratio
9.58
Revenue / Employee
150.23M
Employees
7,604
Market Cap
10.94T

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231,111.37B-148.58B-11.79%
Dec 31, 20221,259.95B260.19B26.02%
Dec 31, 2021999.76B212.81B27.04%
Dec 31, 2020786.95B100.76B14.68%
Dec 31, 2019686.18B106.40B18.35%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Chugai Pharmaceutical News

More News